Recent European Union regulations have significantly reshaped the clinical trials landscape, positioning compliance as a competitive advantage for biopharmaceutical firms. With frameworks such as the EU General Data Protection Regulation (GDPR), the Artificial Intelligence (AI) Act, and the
Mission Bio has unveiled a groundbreaking technology that promises to redefine the landscape of precision oncology. The single-cell genotype and targeted gene expression assay, part of the well-regarded Tapestri Platform, has been introduced as the first commercial solution designed to deliver
The landscape of neurology is undergoing a seismic shift as new advancements in research and treatment redefine approaches to longstanding neurological diseases. Historically, the focus has been on managing symptoms, often overlooking deeper disease mechanisms and progression. Today, this is
The integrity of clinical trials remains an ever-present concern within the medical and scientific communities. One of the most pressing issues threatening this integrity is the participation of duplicate and professional research subjects. These individuals, who simultaneously or successively
Ivan Kairatov's extensive experience in research and development within the biopharma industry offers invaluable insights into the innovative approaches transforming precision oncology. Today, he shares his expertise on the recent advancements in treating soft tissue sarcomas (STS), emphasizing the
The urgent need for innovative treatments in diabetic retinopathy, a primary cause of blindness among working-age adults worldwide, captures significant attention. With both type 1 and type 2 diabetes contributing to the condition, diabetic retinopathy occurs due to the deterioration of blood
